Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$3.28 - $4.81 $3.08 Million - $4.52 Million
-940,512 Reduced 70.79%
388,019 $1.34 Million
Q4 2022

Feb 14, 2023

SELL
$3.65 - $4.82 $594,585 - $785,178
-162,900 Reduced 10.92%
1,328,531 $5.95 Million
Q3 2022

Nov 14, 2022

SELL
$2.66 - $3.97 $1.04 Million - $1.56 Million
-391,931 Reduced 20.81%
1,491,431 $5.43 Million
Q2 2022

Aug 15, 2022

BUY
$2.42 - $4.05 $1.5 Million - $2.5 Million
618,107 Added 48.85%
1,883,362 $4.99 Million
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $1.4 Million - $2.36 Million
405,324 Added 47.13%
1,265,255 $5.01 Million
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $646,027 - $1 Million
132,112 Added 18.15%
859,931 $4.26 Million
Q3 2021

Nov 12, 2021

SELL
$5.18 - $7.41 $5.44 Million - $7.78 Million
-1,050,453 Reduced 59.07%
727,819 $4.76 Million
Q2 2021

Aug 16, 2021

BUY
$3.94 - $6.75 $4.11 Million - $7.04 Million
1,043,183 Added 141.91%
1,778,272 $11.7 Million
Q1 2021

May 17, 2021

BUY
$4.03 - $7.25 $833,295 - $1.5 Million
206,773 Added 39.14%
735,089 $3.2 Million
Q4 2020

Feb 16, 2021

BUY
$2.78 - $4.5 $254,269 - $411,588
91,464 Added 20.94%
528,316 $2.02 Million
Q3 2020

Nov 16, 2020

BUY
$2.12 - $3.53 $45,853 - $76,350
21,629 Added 5.21%
436,852 $1.53 Million
Q2 2020

Aug 14, 2020

BUY
$1.66 - $2.73 $139,008 - $228,610
83,740 Added 25.26%
415,223 $930,000
Q1 2020

May 14, 2020

BUY
$1.35 - $4.05 $137,832 - $413,496
102,098 Added 44.51%
331,483 $828,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $61,322 - $122,645
-26,662 Reduced 10.41%
229,385 $968,000
Q3 2019

Nov 14, 2019

BUY
$2.9 - $9.56 $51,785 - $170,712
17,857 Added 7.5%
256,047 $743,000
Q2 2019

Aug 15, 2019

BUY
$6.7 - $9.13 $1.6 Million - $2.17 Million
238,190 New
238,190 $2.1 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.